Novel study evaluates systemic mastocytosis’ effect on patients, providers
Blueprint Medicines released results from the largest-ever European study evaluating the effect of systemic mastocytosis on patients’ lives.
Larry Luxner
Larry is a freelance journalist and photographer who specializes in covering the rare disease community.
